Claudia Saracini

Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients

Betti Giusti, Anna Maria Gori, Rossella Marcucci et al. · Pharmacogenetics and Genomics · 2007 · 229 citations

Medicine, Cardiology, Pharmacology +17

Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis

Betti Giusti, Anna Maria Gori, Rossella Marcucci et al. · The American Journal of Cardiology · 2009 · 223 citations · Full text

Medicine, Cardiology, Pharmacology +16

Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm

Betti Giusti, Claudia Saracini, Peter Bolli et al. · Journal of Medical Genetics · 2008 · 67 citations

Life Sciences, Genetics, Molecular Genetics +16

Early-onset ischaemic stroke: Analysis of 58 polymorphisms in 17 genes involved in methionine metabolism

Claudia Saracini, Paola Bolli, Alberto Magi et al. · Thrombosis and Haemostasis · 2010 · 43 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Role of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment

Betti Giusti, Anna Maria Gori, Rossella Marcucci et al. · Atherosclerosis · 2006 · 39 citations · Full text

Medicine, Cardiology, Hematology +17